相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SUMO-specific protease 2 mediates leptin-induced fatty acid oxidation in skeletal muscle
Young Do Koo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Obesity, kidney dysfunction and hypertension: mechanistic links
John E. Hall et al.
NATURE REVIEWS NEPHROLOGY (2019)
ATRQβ-001 Vaccine Prevents Experimental Abdominal Aortic Aneurysms
Hongrong Zhang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Partial Leptin Reduction as an Insulin Sensitization and Weight Loss Strategy
Shangang Zhao et al.
CELL METABOLISM (2019)
Insulin-Like Growth Factor Binding Protein 1 Could Improve Glucose Regulation and Insulin Sensitivity Through Its RGD Domain
Natalie J. Haywood et al.
DIABETES (2017)
Angiotensin AT1A receptors on leptin receptor-expressing cells control resting metabolism
Kristin E. Claflin et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
The glucoregulatory actions of leptin
Anna M. D'souza et al.
MOLECULAR METABOLISM (2017)
Telmisartan Ameliorates Nephropathy in Metabolic Syndrome by Reducing Leptin Release From Perirenal Adipose Tissue
Hao Li et al.
HYPERTENSION (2016)
Usual Blood Pressure and New-Onset Diabetes Risk
Joshua W. Knowles et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research
Zhixiang Wang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Leptin Rapidly Induces the Expression of Metabolic and Myokine Genes in C2C12 Muscle Cells to Regulate Nutrient Partition and Oxidation
Yuriy Nozhenko et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Obesity-Induced Hypertension Interaction of Neurohumoral and Renal Mechanisms
John E. Hall et al.
CIRCULATION RESEARCH (2015)
Insulin resistance and hypertension: new insights
Manoocher Soleimani
KIDNEY INTERNATIONAL (2015)
Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats
Helge Mueller-Fielitz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Chronic blockade of angiotensin AT1 receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats
Helge Mueller-Fielitz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Telmisartan Improves Insulin Resistance of Skeletal Muscle Through Peroxisome Proliferator-Activated Receptor-δ Activation
Li Li et al.
DIABETES (2013)
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
Hyun-Seuk Moon et al.
ENDOCRINE REVIEWS (2013)
Effectiveness and Safety of a Therapeutic Vaccine Against Angiotensin II Receptor Type 1 in Hypertensive Animals
Xiao Chen et al.
HYPERTENSION (2013)
A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
Gianluigi Savarese et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice
Asuka Shiota et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Insulin Resistance and Type 2 Diabetes
Roy Taylor
DIABETES (2012)
Leptin revisited: its mechanism of action and potential for treating diabetes
Roberto Coppari et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
The role of leptin in glucose homeostasis
Heather C. Denroche et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
Valsartan Improves β-Cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Metabolism A randomized controlled trial
Nynke J. van der Zijl et al.
DIABETES CARE (2011)
The renin-angiotensin-aldosterone system and glucose homeostasis
James Matthew Luther et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Disruption of Hepatic Leptin Signaling Protects Mice From Age- and Diet-Related Glucose Intolerance
Frank K. Huynh et al.
DIABETES (2010)
Leptin Deficiency Causes Insulin Resistance Induced by Uncontrolled Diabetes
Jonathan P. German et al.
DIABETES (2010)
Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
X. Rong et al.
DIABETOLOGIA (2010)
Telmisartan Prevents Weight Gain and Obesity Through Activation of Peroxisome Proliferator-Activated Receptor-δ-Dependent Pathways
Hongbo He et al.
HYPERTENSION (2010)
Leptin regulates ACE activity in mice
Aline Mourao Hilzendeger et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Central leptin action improves skeletal muscle AKT, AMPK, and PGC1α activation by hypothalamic PI3K-dependent mechanism
Erika A. F. R. Roman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-γ activation
Firas Younis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Ralph A. DeFronzo et al.
DIABETES CARE (2009)
An Adipose Tissue-Independent Insulin-Sensitizing Action of Telmisartan: a Study in Lipodystrophic Mice
X. Rong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Leptin and cardiovascular disease - Response to therapeutic interventions
Kwang Kon Koh et al.
CIRCULATION (2008)
Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2 dependent pathway
T Skurk et al.
OBESITY RESEARCH (2005)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis
SH Bates et al.
CELL METABOLISM (2005)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Transactivation joins multiple tracks to the ERK/MAPK cascade
R Wetzker et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Y Minokoshi et al.
NATURE (2002)
分享论文
